Fuyuan Pharmaceutical: Pioglitazone Metformin Tablets Obtained Drug Registration Certificate

Fuyuan Pharmaceuticals announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for pioglitazone metformin hydrochloride tablets and metformin hydrochloride 850mg tablets, approving the production of the drug.